RNA-targeted small-molecule drug discoveries: a machine-learning perspective.

Area of Science:

• Biochemistry
• Computational Biology
• Drug Discovery

Background:

• Machine learning (ML) is widely used for protein-targeted small molecule (SM) discovery.
• Applying ML to RNA-targeted SM discovery is nascent due to RNA's structural instability.
• Recent advances in RNA structure elucidation and ligand identification fuel interest in RNA-targeted therapeutics.

Purpose of the Study:

• To explore the application of ML in accelerating RNA-targeted small molecule discovery.
• To highlight the potential of intracellular RNA as a therapeutic target.
• To leverage existing RNA research data for ML-driven drug development.

Main Methods:

• Review of current ML applications in drug discovery.
• Discussion of challenges in RNA structure-based screening and design.
• Exploration of integrating ML with experimental processes for RNA targets.

Main Results:

• ML models can rapidly screen large molecular libraries once trained.
• RNA's structural instability presents a significant hurdle for traditional screening.
• Increased research is making RNA a viable alternative therapeutic target.

Conclusions:

• ML holds significant potential to enhance the speed and efficiency of RNA-targeted drug discovery.
• Targeting intracellular RNA offers a major therapeutic alternative to proteins.
• Availability of RNA-related data is crucial for successful ML implementation in this field.